Selecta taps Ginkgo to create better capsids for gene therapy delivery
Selecta taps Ginkgo to create better capsids for gene therapy [...]
Selecta taps Ginkgo to create better capsids for gene therapy [...]
Kyowa sells U.S. rights to cancer drug delivery patch to [...]
Recipharm unloads a pair of plants in separate deals as [...]
Eyeing its post-Humira future, AbbVie angles for broader Rinvoq use [...]
#JPM22, Day 1: Bristol Myers Squibb’s blockbuster losses of exclusivity, [...]
Catalent FDA write-up ‘allegedly’ the culprit behind Novo Nordisk’s Wegovy [...]
CEO pay for Pfizer, J&J, Moderna and AstraZeneca should be [...]
Merck’s Keytruda scores key NICE sign-off for first-line NSCLC indication [...]
FDA must hit the gas on FOIA request tied to [...]
Regeneron hands over Evkeeza rights to Ultragenyx outside US, with [...]